← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4.
InvestVerdict

Kotak NIFTY 100 Low Volatility 30 Index Fund

Regular Plan · Growth · Index Funds · Scheme code 152664

Fund houseKotak Mahindra Mutual Fund
CategoryIndex Funds
Plan & optionRegular · Growth
History2.2 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme -1.364.08-1.00 0.08—— ——3.35
Nifty 100
benchmark
0.253.49-1.52 1.8410.529.38 ——12.79
Index Funds
category median
——— -3.897.275.88 —10.77—

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fallR²
This scheme 14.7% -0.21 -0.27 0.93 0.88% -18.4% 87.96
Nifty 100
benchmark
14.4%0.28 0.40—— -37.0%—

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 26 months this scheme and its benchmark share.

Growth of ₹100 since launch

921001091172026InvestVerdict

Drawdown from peak (%)

0%-7%-14%-21%2026

Every one-year period it has lived through

WindowsWorstMedianBestPeriods that lost money
301 -7.9% 2.5% 13.4% 35%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

How it behaves against its benchmark

Up captureDown captureCorrelation Tracking errorInformation ratioTreynor
91% 82% 0.94 5.2% 0.24 -4.01

Up capture is how much of the benchmark's gain this scheme kept in the months the benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it on the up side is the combination every fund is trying for and few reach. Measured over the 26 months this scheme and Nifty 100 share.

InvestVerdict

Kotak NIFTY 100 Low Volatility 30 Index Fund

Regular Plan · Growth

Allocation

By asset

Equity99.98%
Cash & Equivalents0.02%

By market cap

Large Cap96.75%
Mid Cap3.23%

Concentration

Number of stocks30
Top 5 stocks18.94%
Top 10 stocks36.87%
Top 20 stocks70.31%
Lines in the filing32
Largest holding3.84%
Largest sectorBanks 13.94%
Effective stocks29.7
Sectors held16
Cash0.02%

Effective stocks is what the concentration works out to: a fund holding 30 names but most of its money in a few behaves like a fund of 30. Cash includes repo and TREPS, which every fund parks money in overnight.

Sector split

Banks — 13.9%Pharmaceuticals and Biotechnology — 13.8%Power — 10.6%Food Products — 7.2%Insurance — 6.9%Diversified FMCG — 6.9%Automobiles — 6.3%Consumer Durables — 6.1%IT - Software — 5.4%Other — 23.1%Banks13.9%Pharmaceuticals and Biote…13.8%Power10.6%Food Products7.2%Insurance6.9%Diversified FMCG6.9%Automobiles6.3%Consumer Durables6.1%IT - Software5.4%Other23.1%
Banks13.94%
Pharmaceuticals and Biotechnology13.79%
Power10.60%
Food Products7.21%
Insurance6.89%
Diversified FMCG6.87%
Automobiles6.29%
Consumer Durables6.05%
IT - Software5.41%
Healthcare Services3.81%
Telecom - Services3.65%
Petroleum Products3.47%
Cement and Cement Products3.15%
Finance3.02%
Chemicals and Petrochemicals2.97%
Construction2.86%
0.20%
InvestVerdict

Kotak NIFTY 100 Low Volatility 30 Index Fund

Regular Plan · Growth · holdings

Top 30 holdings

#CompanySectorShares held Value
₹ cr
% of fund
1 ICICI BANK LTD. Banks 29,716 4 3.84%
2 SUN PHARMACEUTICAL INDUSTRIES LTD. Pharmaceuticals and Biotechnology 21,487 4 3.82%
3 Apollo Hospitals Enterprise Ltd. Healthcare Services 4,765 4 3.81%
4 NTPC LTD Power 120,101 4 3.79%
5 Britannia Industries Ltd. Food Products 7,779 4 3.68%
6 BHARTI AIRTEL LTD. Telecom - Services 21,227 4 3.65%
7 KOTAK MAHINDRA BANK LTD. Banks 88,959 4 3.63%
8 SBI Life Insurance Company Ltd Insurance 21,786 4 3.62%
9 Nestle India Ltd. Food Products 27,499 4 3.53%
10 ITC Ltd. Diversified FMCG 136,015 4 3.50%
11 RELIANCE INDUSTRIES LTD. Petroleum Products 29,858 4 3.47%
12 Tata Power Company Ltd. Power 97,466 4 3.42%
13 Cipla Ltd. Pharmaceuticals and Biotechnology 25,946 3 3.42%
14 Power Grid Corporation of India Ltd. Power 133,097 3 3.39%
15 HDFC BANK LTD. Banks 48,899 3 3.39%
16 Hindustan Unilever Ltd. Diversified FMCG 18,346 3 3.37%
17 TORRENT PHARMACEUTICALS LTD. Pharmaceuticals and Biotechnology 7,064 3 3.32%
18 HDFC Life Insurance Company Ltd Insurance 64,141 3 3.27%
19 Dr.Reddy's Laboratories Ltd. Pharmaceuticals and Biotechnology 26,773 3 3.23%
20 Maruti Suzuki India Limited Automobiles 2,701 3 3.16%
21 Ultratech Cement Ltd. Cement and Cement Products 2,942 3 3.15%
22 Bajaj Auto Ltd. Automobiles 2,937 3 3.13%
23 STATE BANK OF INDIA. Banks 32,825 3 3.08%
24 Asian Paints(India) Ltd. Consumer Durables 12,937 3 3.04%
25 Bajaj Finserv Ltd. Finance 17,823 3 3.02%
26 TITAN COMPANY LTD. Consumer Durables 6,713 3 3.01%
27 Pidilite Industries Ltd. Chemicals and Petrochemicals 20,717 3 2.97%
28 Larsen and Toubro Ltd. Construction 7,772 3 2.86%
29 Wipro Ltd. IT - Software 182,030 3 2.82%
30 TATA CONSULTANCY SERVICES LTD. IT - Software 12,885 3 2.59%
InvestVerdict

Kotak NIFTY 100 Low Volatility 30 Index Fund

Regular Plan · Growth · where the money sits

What the manager did last month

Between the filings of 30 Jun 2026 and 31 Jul 2026. A position grows because the manager bought or because the price rose; only the share count separates them.

BoughtSoldNew positionsSold out ofPrice move of holdings
₹0 cr ₹3 cr 0 0 +5.01%
StockShares tradedShares PriceValue
₹ cr
Trimmed
INE090A01021 956 -2.9% +4.4% 0.1
INE123W01016 693 -2.9% +6.6% 0.1
INE044A01036 651 -2.9% +6.9% 0.1
INE239A01024 850 -2.9% +7.4% 0.1
INE397D01024 651 -2.9% +6.5% 0.1
INE917I01010 112 -2.9% +18.6% 0.1
INE733E01010 3,652 -2.9% -2.6% 0.1
INE437A01024 140 -2.9% +3.2% 0.1
Not equityPrevious filingThis filingChange
Cash, repo and TREPS ₹0 cr ₹0 cr +₹0 cr

The list above is stocks and fund units. Treasury bills, repo and money-market lines roll over every month by design — they are not decisions, so they are totalled here rather than listed as activity.

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 31 Oct 2026.